NovoCure Ltd (NVCR)
14.77
+0.58
(+4.09%)
USD |
NASDAQ |
May 03, 16:00
14.77
0.00 (0.00%)
After-Hours: 20:00
NovoCure Cash from Investing (Quarterly): 98.50M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 98.50M |
| September 30, 2023 | 17.26M |
| June 30, 2023 | -13.90M |
| March 31, 2023 | 82.29M |
| December 31, 2022 | -128.06M |
| September 30, 2022 | -150.24M |
| June 30, 2022 | 155.76M |
| March 31, 2022 | -17.41M |
| December 31, 2021 | -499.09M |
| September 30, 2021 | 302.70M |
| June 30, 2021 | -2.618M |
| March 31, 2021 | 54.17M |
| December 31, 2020 | -613.64M |
| September 30, 2020 | 147.22M |
| June 30, 2020 | -3.315M |
| March 31, 2020 | -3.112M |
| December 31, 2019 | -46.76M |
| September 30, 2019 | -2.174M |
| Date | Value |
|---|---|
| June 30, 2019 | -1.748M |
| March 31, 2019 | -0.989M |
| December 31, 2018 | -1.789M |
| September 30, 2018 | -1.005M |
| June 30, 2018 | -0.842M |
| March 31, 2018 | -1.857M |
| December 31, 2017 | -1.946M |
| September 30, 2017 | -1.753M |
| June 30, 2017 | -0.586M |
| March 31, 2017 | 12.91M |
| December 31, 2016 | -3.41M |
| September 30, 2016 | -4.414M |
| June 30, 2016 | -6.625M |
| March 31, 2016 | 27.44M |
| December 31, 2015 | -126.04M |
| September 30, 2015 | 27.36M |
| June 30, 2015 | -37.90M |
| March 31, 2015 | 21.28M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-613.64M
Minimum
Dec 2020
302.70M
Maximum
Sep 2021
-32.85M
Average
-2.618M
Median
Jun 2021
Cash from Investing (Quarterly) Benchmarks
| AtriCure Inc | 9.644M |
| NeuroMetrix Inc | 0.098M |
| Repligen Corp | -8.362M |
| Teleflex Inc | -563.53M |
| Perspective Therapeutics Inc | -0.089M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -14.56M |
| Cash from Financing (Quarterly) | 1.91M |
| Free Cash Flow | -100.43M |
| Free Cash Flow Per Share (Quarterly) | -0.20 |
| Free Cash Flow to Equity (Quarterly) | -22.22M |
| Free Cash Flow to Firm (Quarterly) | -21.38M |
| Free Cash Flow Yield | -6.39% |